Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALY
4426
Callaway Golf Company
CALY
$2.94B
| $3.5M | ﹤0.01% |
181,858
-476,930
| -72% | -$10.5M |
|
|
GBT
4427
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.5M | ﹤0.01% |
51,397
-1,300,157
| -96% | -$71.7M |
|
4428
PUT
ProShares UltraShort S&P500
SDS
$366M
| $3.5M | ﹤0.01% |
12,820
-10,316
| -45% | -$2.33M |
|
4429
CALL
Ameren
AEE
$30.4B
| $3.5M | ﹤0.01% |
43,400
+33,500
| +338% | +$3.06M |
|
|
AMED
4430
CALL
DELISTED
Amedisys
AMED
| $3.49M | ﹤0.01% |
36,100
-11,800
| -25% | -$1.41M |
|
4431
CALL
Astrana Health
ASTH
$2.02B
| $3.49M | ﹤0.01% |
89,600
+75,400
| +531% | +$3.45M |
|
4432
Carnival Corporation Ltd
CCL
$38.5B
| $3.49M | ﹤0.01% |
496,666
-1,129,378
| -69% | -$10.9M |
|
4433
PUT
First Trust Cloud Computing ETF
SKYY
$3.31B
| $3.49M | ﹤0.01% |
57,800
+29,100
| +101% | +$2.01M |
|
4434
Stoke Therapeutics
STOK
$2.02B
| $3.49M | ﹤0.01% |
271,781
+146,544
| +117% | +$2.34M |
|
4435
PUT
Edison International
EIX
$27.5B
| $3.48M | ﹤0.01% |
61,600
+18,600
| +43% | +$1.23M |
|
4436
CALL
Levi Strauss
LEVI
$8.68B
| $3.48M | ﹤0.01% |
240,800
+92,400
| +62% | +$1.65M |
|
4437
CALL
Jacobs Solutions
J
$16.9B
| $3.48M | ﹤0.01% |
38,808
-71,208
| -65% | -$7.38M |
|
|
BIG
4438
PUT
DELISTED
Big Lots, Inc.
BIG
| $3.48M | ﹤0.01% |
223,100
+45,800
| +26% | +$985K |
|
4439
Stepan Co
SCL
$1.48B
| $3.48M | ﹤0.01% |
37,160
-900
| -2% | -$93.6K |
|
4440
Clean Energy Fuels
CLNE
$403M
| $3.48M | ﹤0.01% |
650,910
+326,060
| +100% | +$2.04M |
|
4441
Core Laboratories
CLB
$571M
| $3.47M | ﹤0.01% |
257,747
+63,340
| +33% | +$1.07M |
|
4442
CALL
ZipRecruiter
ZIP
$386M
| $3.47M | ﹤0.01% |
210,500
-105,600
| -33% | -$1.84M |
|
4443
CALL
Helen of Troy
HELE
$704M
| $3.47M | ﹤0.01% |
36,000
+10,000
| +38% | +$1.29M |
|
4444
EyePoint Inc
EYPT
$1.27B
| $3.47M | ﹤0.01% |
438,872
-602,145
| -58% | -$5.59M |
|
4445
PUT
Host Hotels & Resorts
HST
$15.7B
| $3.47M | ﹤0.01% |
218,400
+135,600
| +164% | +$2.36M |
|
|
NSTC
4446
DELISTED
Northern Star Investment Corp. III
NSTC
| $3.47M | ﹤0.01% |
352,091
-755
| -0.2% | -$7.42K |
|
|
PDCE
4447
PUT
DELISTED
PDC Energy, Inc.
PDCE
| $3.46M | ﹤0.01% |
59,900
-37,400
| -38% | -$2.29M |
|
4448
PUT
Qiagen
QGEN
$8.87B
| $3.46M | ﹤0.01% |
79,028
+62,525
| +379% | +$3.09M |
|
4449
Olema Pharmaceuticals
OLMA
$930M
| $3.46M | ﹤0.01% |
1,252,942
-228,273
| -15% | -$968K |
|
|
AERI
4450
DELISTED
Aerie Pharmaceuticals
AERI
| $3.46M | ﹤0.01% |
228,542
+136,585
| +149% | +$1.59M |
|
Similar funds
Ken Griffin's Q3 2022 Portfolio in Review
As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
- Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.